Boyds Acquires New Cambridge Office to Support Rapid Growth
Boyds, the drug development consultancy which helps pharmaceutical companies translate great science into marketable medicines for patient benefit, has relocated into new premises in Cambridge.
The company has invested in excess of £0.5m in the purchase and complete refurbishment of a 1700 sq ft building located at South Cambridge Business Park in Sawston.
Boyds was previously located in Cottenham, a village on the outskirts of the city, and its head office will remain in Crewe, Cheshire.
Professor Alan Boyd, CEO and founder of Boyds said the team had outgrown its former property after a period of swift growth.
He said: “Our team has grown significantly in the last 12 months and we needed more space so we could futureproof our building for further new capacity in the months and years ahead.
“We remain in a prime location, close to academic groups, start-up hubs and industry, with several science parks within a five-mile radius.
“We also now have a dedicated meeting room facility that can support large client meetings and seminars.”
Professor Boyd said Boyds was committed to Cambridge as the city continues to be a thriving scientific hub that is recognised globally for its excellence in innovative research, and can be easily reached from London.
He added: “Cambridge is an ideal location for Boyds as it is optimally aligned with our goal to provide expert consultancy services for clients globally who are focusing on innovative products and treatment approaches.”
Targeted Drug Could be Used to Treat Advanced Cancers Located Anywhere in the BodyNews
A new targeted drug could be used to treat a small number of advanced cancers no matter where they grow in the body.READ MORE
Human Malaria Parasites Grown for the First Time in Dormant FormNews
One of the biggest obstacles to eradicating malaria is a dormant form of the parasite which is resistant to most antimalarial drugs and can reawaken years later, causing disease relapse. Researchers have shown they can grow the dormant parasite in engineered human liver tissue for several weeks, allowing them to closely study how the parasite becomes dormant, what vulnerabilities it may have, and how it springs back to life.READ MORE
Bacteria Produce More Substances Than Genetics PredictedNews
Tandem mass spectrometry has revealed that Streptomyces chartreusis, an antibiotic-producing bacterium, releases more metabolites into the surrounding medium than scientists assumed based on the analysis of the genome. They might include molecules that are of interest as potential pharmaceutical agents.READ MORE